sports technology labs semaglutide GLP-1 Drugs: 6 Things We've Learned About Their Effects Semaglutide (GLP-1) Muscle Loss: Body

Examining the Evidence As of April 2024, there is no established clinical evidence linking Mounjaro (tirzepatide) directly to an increased risk of blood clots or venous thromboembolism

The study did not find a correlation between whole-blood serotonin levels and sleep or emotional problems

Retatrutide is a novel synthetic peptide that functions as a triple receptor agonist, acting on the GLP-1, GIP, and glucagon receptors

BMI-Based Eligibility for Weight Loss Most healthcare providers follow criteria similar to those established for FDA-approved weight loss medications: BMI of 30 or higher (obesity): You may qualify for Ozempic off-label for weight loss if your BMI indicates obesity, even without weight-related health conditions

Retatrutide has no MHRA marketing authorisation, making it unlawful to sell, supply, or import as a medicinal product under the Human Medicines Regulations 2012

Science Day is set for September 4, 2024